Evidence map›Paper›PMID 23290632›Full record

ArticleThe International journal on drug policy2013

A decline in the prevalence of injecting drug users in Estonia, 2005-2009.

Anneli Uusküla, Kristiina Rajaleid, Ave Talu, Katri Abel-Ollo, Don C Des Jarlais

Abstract read
In one paragraph

Article in The International journal on drug policy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Estonia, July to December 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future.Journal of urban health : bulletin of the New York Academy of Medicine · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Anneli UuskülaDepartment of Public Health, University of Tartu, Tartu, Estonia. anneli.uuskula@ut.ee
Kristiina Rajaleid
Ave Talu
Katri Abel-Ollo
Don C Des Jarlais
National Institute for Health Development · EEMount Sinai Beth Israel · USStockholm University · SEUniversity of Tartu · EE

Funding

Multiple HIV Prevention Packages for IDUs in EstoniaR01AI083035 · NIAID · BETH ISRAEL MEDICAL CTR (NEW YORK) · PI DES JARLAIS, DON C · 2009 to 2012
$2.5M
NIAID NIH HHS R01 AI083035
6 · The paper itself

Abstract

aimsHere we report a study aimed at estimating trends in the prevalence of injection drug use between 2005 and 2009 in Estonia.

backgroundDescriptions of behavioural epidemics have received little attention compared with infectious disease epidemics in Eastern Europe.

methodsThe number of injection drug users (IDUs) aged 15-44 each year between 2005 and 2009 was estimated using capture-recapture methodology based on 4 data sources (2 treatment data bases: drug use and non-fatal overdose treatment; criminal justice (drug related offences) and mortality (injection drug use related deaths) data). Poisson log-linear regression models were applied to the matched data, with interactions between data sources fitted to replicate the dependencies between the data sources. Linear regression was used to estimate average change over time.

resultsThere were 24305, 12,292, 238, 545 records and 8100, 1655, 155, 545 individual IDUs identified in the four capture sources (police, drug treatment, overdose, and death registry, accordingly) over the period 2005-2009. The estimated prevalence of IDUs among the population aged 15-44 declined from 2.7% (1.8-7.9%) in 2005 to 2.0% (1.4-5.0%) in 2008, and 0.9% (0.7-1.7%) in 2009. Regression analysis indicated an average reduction of about 1600 injectors per year.

conclusionWhile the capture-recapture method has known limitations, the results are consistent with other data from Estonia. Identifying the drivers of change in the prevalence of injection drug use warrants further research.

Indexed as

Research DesignAdolescentAdultData CollectionEstoniaFemaleHumansLinear ModelsMalePoisson DistributionPrevalenceSubstance Abuse, IntravenousTime FactorsYoung AdultEastern EuropeHIVIDUInjection drug userPrevalence

Identifiers

PMID23290632
PMCPMC3639300
OpenAlexW1980244460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.